Key facts
- This page summarizes Alan M. Garber's Form 4 filing for EXELIXIS, INC. (EXEL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Mar 2024, 19:31.
Alan M. Garber - 21 Mar 2024 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- Director
- Issuer ticker
- EXEL
- Reported as of
- 21 Mar 2024
- Net transaction value
- -$1,393
- SEC form
- 4
- Accepted by SEC
- 25 Mar 2024, 19:31:20 UTC
- Prior SEC filing
- 02 Jun 2023
- Next SEC filing
- 03 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nina Ayer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alan M. Garber filed Form 4 for EXELIXIS, INC. (EXEL) on 25 Mar 2024.
Change
- Previous filing in this sequence was filed on 02 Jun 2023.
- Current net transaction value: -$1,393.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $459,719
- Shares
- +23,491
- Change %
- +75%
- Price
- $19.57
- Shares after
- 54,908
- Date
- 21 Mar 2024
- Ownership
- Direct
EXEL
transaction
Common Stock
Sale
- Transaction value
- $461,112
- Shares
- -19,205
- Change %
- -35%
- Price
- $24.01
- Shares after
- 35,703
- Date
- 21 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -23,491
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 21 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,491
- Exercise price
- $19.57
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2023.
Footnote F2
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Footnote F3
The option, representing the right to purchase a total of 23,491 shares of Exelixis, Inc. common stock became fully exercisable on May 25, 2017.